The Development of a Fuzzy Logic System Using MATLAB for Early Detection of Hereditary Cancer in BRCA1/2 Negative
N Senturk1, G P Volkan2, Babiker Ali Sm3
1Department of Biomedical Engineering, Faculty of Engineering, Near East University, Nicosia 99138, Cyprus.
Balkan Journal of Medical Genetics : BJMG
|November 7, 2025
Summary
This study developed AI software using fuzzy logic to rapidly detect hereditary breast cancer (BC) in patients with negative BRCA1/2 genes. The tool aids early classification and interpretation of genetic variants for improved diagnosis.
Area of Science:
- Medical Informatics
- Computational Biology
- Genetics
Background:
- Hereditary breast cancer (BC) poses a significant health challenge.
- Accurate and early detection of BC, especially in BRCA1/2-negative cases, is crucial for effective treatment.
- Existing diagnostic tools may benefit from enhanced computational approaches for genetic variant interpretation.
Purpose of the Study:
- To develop and validate an artificial intelligence (AI) software tool for the rapid detection of hereditary breast cancer (BC).
- To utilize a fuzzy logic system in MATLAB to analyze genetic variants associated with BC in individuals with negative BRCA1/2 genes.
- To create a clinical decision-support system integrating clinical and genetic data for early BC classification.
Main Methods:
- Development of a fuzzy logic system using MATLAB to analyze hereditary BC risk factors and gene mutations.
- Integration of clinical and genetic data from 90 relevant patients (out of 488 studied) with negative BRCA1/2 mutations.
- Training the system on 90 cases and validating its accuracy on six independent patients.
Main Results:
- The AI system demonstrated reliable accuracy in assessing genetic variants.
- Identified pathogenic variants with 92% probability, benign variants with 25% probability, and variants of unknown significance with 50% probability.
- The system successfully classified genetic variants based on integrated clinical and genetic data.
Conclusions:
- The developed AI software shows promise as a clinical decision-support tool for early breast cancer detection.
- Fuzzy logic systems can be effectively applied to interpret complex genetic data for BC risk assessment.
- Further research and clinical application of this AI tool could significantly advance hereditary breast cancer diagnosis.


